Skip to Content

WATSON 335 (Acyclovir 400 mg)

Pill imprint WATSON 335 has been identified as Acyclovir 400 mg.

Acyclovir is used in the treatment of cold sores; herpes simplex, suppression; herpes simplex; ramsay hunt syndrome; herpes zoster (and more), and belongs to the drug class purine nucleosides. There is no proven risk in humans during pregnancy. Acyclovir 400 mg is not subject to the Controlled Substances Act.

See also related documents.

Acyclovir 400 mg WATSON 335
Acyclovir 400 mg WATSON 335
400 mg
Elliptical / Oval
Prescription only
Drug Class:
Purine nucleosides
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Watson Pharmaceuticals
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-4765 A-S Medication Solutions, LLC (repackager)
54868-3997 Physicians Total Care Inc (repackager)
55887-0246 Diversified Healthcare Services Inc (repackager)
13411-0182 Advanced Pharmaceutical Services Inc (repackager)
63874-0500 Altura Pharmaceuticals Inc (repackager)
53002-0008 Pharmedix (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.